Decoding the molecular landscape: HER2 and PD-L1 in advanced gastric cancer
{{output}}
Introduction: Epidermal growth factor receptor 2 (HER2) and programmed cell death ligand 1 (PD-L1) are pivotal therapeutic targets for advanced gastric cancer (GC). Nevertheless, the correlation between them, along with the clini... ...
